FDA clearance for Siemens Healthineers mammography system

Siemens Healthineers announced that the FDA has cleared its MAMMOMAT Revelation mammography system.

New features included with the MAMMOMAT Revelation include the InSpect imaging tool and a HD Breast Biopsy solution that can target suspicious areas with a single click. The system also adjusts the level of breast compression for each patient and offers providers the option of performing titanium contrast-enhanced mammography.

“MAMMOMAT Revelation is another example of Siemens Healthineers innovation that aids in early breast cancer detection,” Martin Silverman, vice president of x-ray products for Siemens Healthineers North America, said in a prepared statement.

“Building on the industry’s widest angle in breast tomosynthesis, MAMMOMAT Revelation delivers an improved patient experience. For the first time, healthcare providers have next-generation tools that make a real difference in diagnostic certainty.”